Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis A Vaccines
Data from Pontificia University Catolica of Chile provide new insights into hepatitis a vaccines
June 25th, 2008
Research findings, 'Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children,' are discussed in a new report. In this recently published article, scientists in Santiago, Chile conducted a study "To compare the immunogenicity, safety, and interchangeability of two pediatric hepatitis A vaccines, Avaxim 80U-Pediatric and Havrix 720, in Chilean children. In this randomized trial, 332 hepatitis A virus (HAV) seronegative children from 1 to 15 years of age received two doses of Avaxim, two doses of Havrix, or Havrix followed by Avaxim, 6 months apart." "Anti-HAV antibody titers were measured before and 14 days after the first...
Source: Vaccine Weekly (2008-06-25)
|
